Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0000919574-21-000248

Director bought 2,500,000 shares at $2.60 ($6,500,000)

From the SEC's structured data for this filing

Trades in this filing

ARMISTICE CAPITAL, LLC · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-08 Purchase : show line 1 in the form +2,500,000 $2.60 $6,500,000 32,634,285 D
2021-01-08 Purchase : show line 2 in the form +0 32,634,285 I
Open-market purchases · 2,500,000 sh · avg $2.60 · $6,500,000
Loading xslF345X03/ownership.xml…